A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer
Clinical trial NCT00040092 · COMPLETED
Trial details
- NCT number
- NCT00040092
- Sponsor
- Aptose Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2005-07-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.